Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China flag China · Delayed Price · Currency is CNY
12.29
+0.27 (2.25%)
Oct 23, 2026, 3:04 PM CST

SHE:300003 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
658.24962.01246.941,2582,2041,719
Depreciation & Amortization
638.8638.8560.04513.56488.47448.74
Other Amortization
83.4683.4696.4290.2279.1672.83
Loss (Gain) From Sale of Assets
-4.87-4.87-11.737.871.69-19.9
Asset Writedown & Restructuring Costs
72.1743.83134.7636.59-2.39
Loss (Gain) From Sale of Investments
-54.2-54.289.2913.4470.91367.54
Provision & Write-off of Bad Debts
17.6438.8750.3626.1324.4520.76
Other Operating Activities
507.73369.67284.62337.04278.83308.15
Change in Accounts Receivable
-489.63-489.63-62.843.22-665.0742.85
Change in Inventory
-198.73-198.73206.28-251.01-386.7-494.73
Change in Accounts Payable
168.11168.11-688.65-982710.12660.39
Operating Cash Flow
1,3581,517734.64990.362,7913,062
Operating Cash Flow Growth
2.57%106.48%-25.82%-64.51%-8.86%46.53%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-882.19-643.06-658.82-844.67-905.22-984.4
Sale of Property, Plant & Equipment
0.771.6230.038.522.552.09
Cash Acquisitions
-1.11--21.82-344.92-3.1-453.01
Divestitures
-13.24-13.954.42-48.08-0.15
Investment in Securities
110.36-352.93-237.88-65.41-648.89129.18
Other Investing Activities
244.09182.473.66-428.320.47533.27
Investing Cash Flow
-398.65-690.74-743.9-1,886-1,599-860.46

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Long-Term Debt Issued
-3,1513,1682,6941,8283,745
Long-Term Debt Repaid
--2,580-2,352-2,320-2,601-4,338
Lease Payments
-59.75-59.75-58.21-68.16-85.49-78.89
Total Debt Repaid
-4,108-2,580-2,352-2,320-2,601-4,338
Net Debt Issued (Repaid)
386.46571.51815.96373.41-772.86-592.54
Issuance of Common Stock
3.63---1,533-
Repurchase of Common Stock
---177.43-75.24-245.91-109.91
Common Dividends Paid
-712.74-681.55-990.89-768.66-635.65-587.04
Other Financing Activities
-375.7827.68-132.86177.57534.17392.09
Financing Cash Flow
-698.44-82.36-485.22-292.92412.75-897.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
-63.08-16.788.92-20.5921.13-11.31
Net Cash Flow
198.17727.04-485.56-1,2091,6251,293

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
476.15873.8675.82145.691,8852,078
Free Cash Flow Growth
-33.73%1052.51%-47.96%-92.27%-9.25%39.48%
Free Cash Flow Margin
7.72%13.48%1.24%1.83%17.77%19.49%
Free Cash Flow Per Share
0.260.470.040.081.041.15
Levered Free Cash Flow
2,137-131.9736.41-338.091,6031,479
Unlevered Free Cash Flow
2,303-21.57149.53-231.431,7211,622
Free Cash Flow After Leases
416.4814.1117.6177.531,8001,999

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash Income Tax Paid
124.33614.84775.28970.56962.96725.21
Change in Working Capital
-560.65-560.65-716.06-1,293-356.6142.15